Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Anemia 3Multiple Myeloma 2Lymphoma, Non-Hodgkin 2Leukemia, Lymphocytic, Chronic, B-Cell 2Ovarian Neoplasms 1Neoplasms, Plasma Cell 1Neoplasms 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma 1Lung Neoplasms 1Leukemia 1Iron Deficiencies 1Hematologic Neoplasms 1Gynecologic Cancer 1Carcinoma, Ovarian Epithelial 1Carcinoma, Intraductal, Noninfiltrating 1Carcinoma, Ductal, Breast 1Breast Neoplasms 1Anemia, Iron-Deficiency 1Anaemia in Ovarian Carcinoma 1

Interventions

Standard of Care 2Brachytherapy 2genexol-PM 1gadobutrol 1fosaprepitant 1Surveys and Questionnaires 1Sex 1Radiotherapy, Intensity-Modulated 1Psychotherapy 1Prochlorperazine 1Preoperative Exercise 1Population Groups 1Ondansetron 1Olanzapine 1Neurokinin-1 Receptor Antagonists 1NK Cell Lectin-Like Receptor Subfamily B 1Imagery, Psychotherapy 1FloSeal Matrix 1Ferric Oxide, Saccharated 1Exercise 1Enhanced Recovery After Surgery 1Educational Status 1Drug Therapy 1Dexamethasone 1Cryotherapy 1Counseling 1Cisplatin 1Blood Specimen Collection 1AGuIX 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Gynecologic Cancer × Ferric Oxide, Saccharated × Clear all
NCT01435200 2017-02-01

Intravenous Iron in Gynecologic Cancer Patients Receiving Chemotherapy

Chulalongkorn University

Phase 3 Completed
64 enrolled
Gynecologic

Gynecologic Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡